Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)

Background: Studies comparing drug survival in different anti-tumour necrosis factor (TNF) agents in IBD patients are scarce, especially for second-line anti-TNF agents. We aimed to (A) assess drug survival and predictors of response and adverse drug reactions to first-line anti-TNF treatment and (B...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Crohn's and colitis 2019, Vol.13 (Suppl. 1), p.S443
Hauptverfasser:	Visuri, Isabella, Eriksson, Carl, Mårdberg, E., Grip, O., Gustavsson, A., Hjortswang, H., Karling, P., Montgomery, Scott, Myrelid, P., Olén, O., Ludvigsson, Jonas F., Halfvarson, Jonas
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!